The subject of dimethyltryptamine is gaining heightened attention in Australia. Historically , relatively unheard of within mainstream communities , copyright is now commonly surfacing in conversations regarding {mental health , spiritual exploration , and potential therapeutic applications. This change in perception is fueled by expanding exposure